Changing Course? Explore a Long-Acting Option for Your Patient With Schizophrenia or Bipolar I Disorder

Friday, October 26
12:15 PM - 1:30 PM
Location: W230 A-C

Non-CME. Lunch will be served. Seating is limited.
Uncover the latest information, data, and research findings with disease-state or product-specific presentations. Ask questions of key experts and industry representatives and assess the value to your patient care. Seating is limited and available on a first-come, first-served basis. Innovation Theater presentations are not intended or eligible for CME/CE credit.

Speaker
Roger S. McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Toronto, Canada

Chairman and Executive Director
Brain and Cognition Discovery Foundation
Toronto, Canada

Director, Depression and Bipolar Support Alliance
Chicago, Illinois

Professor and Nanshan Scholar
Guangzhou Medical University
Guangzhou, China

This presentation is provided by Otsuka America Pharmaceutical, Inc. and Lundbeck


Assets

Changing Course? Explore a Long-Acting Option for Your Patient With Schizophrenia or Bipolar I Disorder



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Changing Course? Explore a Long-Acting Option for Your Patient With Schizophrenia or Bipolar I Disorder